Meridian Wealth Management’s ADMA Biologics ADMA Stock Holding History

Meridian Wealth Management’s Portfolio ADMA Stock Details ADMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-17,000	Closed	-$66K	–	547
2022 Q4	$66K	Sell	17,000 -33,000	-66%	-$102K	0.01%	515
2022 Q3	$122K	Sell	50,000 -30,000	-38%	-$72K	0.01%	469
2022 Q2	$158K	Sell	80,000 -70,000	-47%	-$138K	0.01%	520
2022 Q1	$275K	Hold	150,000	–	–	0.03%	328
2021 Q4	$212K	Sell	150,000 -56,000	-27%	-$73.6K	0.02%	376
2021 Q3	$233K	Buy	206,000 +42,000	+26%	+$58.8K	0.03%	355
2021 Q2	$262K	Buy	164,000 +64,000	+64%	+$113K	0.03%	321
2021 Q1	$176K	Hold	100,000	–	–	0.03%	354
2020 Q4	$195K	Buy	100,000 +40,000	+67%	+$84.1K	0.03%	322
2020 Q3	$143K	Buy	60,000 +40,000	+200%	+$110K	0.04%	246
2020 Q2	$58K	Buy	+20,000	New	+$57.5K	0.02%	222

Other funds holding ADMA

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return

Stonepine Capital Management Bend, Oregon $114M AUM 77.6% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.83B AUM 190.64% 1-Year Est. Return

Assenagon Asset Management

Assenagon Asset Management Senningerberg, Luxembourg $77B AUM 50.57% 1-Year Est. Return

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return